NCT05590585: Dupilumab in Adolescent and Adult Skin of Color Participants: Open-label Moderate-to-severe Eczema Trial
- State
- Completed
- Phase
- Phase 4
- People
- 124 taking part
- Started
- 11 Jan 2023
- Primary completion
- 14 Nov 2024
- Arms
- dupilumab
- Results
- Posted on the registry
- 21 Oct 2022: Trial registered
- 11 Jan 2023: Trial started
- 14 Nov 2024: Trial completed
- 2 Jan 2026: Trial results posted